Selection of cognitive tests for trials of therapeutic agents

Lancet Psychiatry. 2016 Jun;3(6):499. doi: 10.1016/S2215-0366(16)30067-0.

Authors

John E Harrison¹, Raymond W Lam², Bernhard T Baune³, Roger S McIntyre⁴

Affiliations

¹ Metis Cognition Ltd, Park House, Kilmington Common, Wiltshire BA12 6QY, UK; Alzheimer Center, Amsterdam, Netherlands. Electronic address: John@metiscog.com.
² Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada.
³ Discipline of Psychiatry, School of Medicine, University of Adelaide, Adelaide, SA, Australia.
⁴ Mood Disorders Psychopharmacology Unit, Toronto Western Hospital, Toronto, ON, Canada.

PMID: 27262042
DOI: 10.1016/S2215-0366(16)30067-0

No abstract available

Publication types

Letter
Comment

MeSH terms

Antidepressive Agents
Cognition
Cognitive Dysfunction*
Depression
Humans
Longitudinal Studies

Substances

Antidepressive Agents